Contract facts
UnrestrictedOral Broad Spectrum Antiviral TLR7 is a federal Unrestricted award for Defense Threat Reduction Agency held by Primmune Therapeutics, Inc. Estimated value $22.5M ($11.3M obligated). Current period of performance ends Aug 31, 2026 (potential Dec 31, 2027). Last award drew 1 bidder. Place of performance: CARLSBAD CA. Related solicitation HDTRA117S0002.
Oral broad spectrum antiviral tlr7. Latest action is a modification.
Recompete timing
PublicCurrent PoP ended Aug 31, 2026 (47 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Want the durability read on HDTRA124C0014? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordPrimmune Therapeutics, Inc — $11.0M obligated across 1 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HDTRA124C0014?
HDTRA124C0014 (Oral broad spectrum antiviral tlr7) is a Defense Threat Reduction Agency award with a potential value of $22.5M, currently held by Primmune Therapeutics, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is HDTRA1-24-C-0014?
HDTRA1-24-C-0014 is the dashed form of PIID HDTRA124C0014 (Oral broad spectrum antiviral tlr7), held by Primmune Therapeutics, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded HDTRA124C0014?
Defense Threat Reduction Agency awarded HDTRA124C0014 to Primmune Therapeutics, Inc (potential $22.5M).
Who is the incumbent on HDTRA124C0014?
Primmune Therapeutics, Inc is the incumbent with $11.0M across 1 related awards in SCOUT’s public footprint. The current period of performance ends Aug 31, 2026.
When does Primmune Therapeutics, Inc’s HDTRA124C0014 come up for recompete?
SCOUT tracks a period-of-performance end of Aug 31, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on HDTRA124C0014? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.